These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20509334)

  • 1. Study of cross-reactivity of Mycobacterium leprae reactive salivary IgA with other environmental mycobacteria.
    Kamble RR; Shinde VS; Madhale SP; Jadhav RS
    Indian J Lepr; 2009; 81(2):63-8. PubMed ID: 20509334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of four semi-synthetic Mycobacterium leprae antigens with sera from healthy populations in endemic and non-endemic areas.
    Douglas JT; Steven LM; Hirsch DS; Fujiwara T; Nelson KE; Madarang MG; Cellona RV
    Lepr Rev; 1992 Sep; 63(3):199-210. PubMed ID: 1406016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum samples from patients with mycobacterial infections cross-react with HIV structural proteins Gp41, p55 and p18.
    Hussain T; Sinha S; Katoch K; Yadav VS; Kulshreshtha KK; Singh I; Sengupta U; Katoch VM
    Lepr Rev; 2007 Jun; 78(2):137-47. PubMed ID: 17824484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.
    Melsom R; Harboe M; Duncan ME
    Clin Exp Immunol; 1982 Sep; 49(3):532-42. PubMed ID: 6756719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary immunoglobulins and antibody activities in leprosy.
    Abe M; Yoshino Y; Minagawa F; Miyaji I; Sampoonachot P; Ozawa T; Sakamoto Y; Saito T; Saikawa K
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):343-50. PubMed ID: 6541202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.
    Melsom R; Harboe M; Myrvang B; Godal T; Belehu A
    Clin Exp Immunol; 1982 Feb; 47(2):225-33. PubMed ID: 7042137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The isolation of monoclonal antibodies to strains of Mycobacterium leprae passed through laboratory animals].
    Ibragimov ChD; Iushchenko AA; Diachina MN; Sviridov VV; Chernousova LN
    Probl Tuberk; 1993; (6):45-7. PubMed ID: 8290533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment.
    Melsom R; Harboe M; Naafs B
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):271-81. PubMed ID: 6754639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells.
    Ottenhoff TH; Klatser PR; Ivanyi J; Elferink DG; de Wit MY; de Vries RR
    Nature; 1986 Jan 2-8; 319(6048):66-8. PubMed ID: 2417123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of species specific and cross-reactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies.
    Ivanyi J; Sinha S; Aston R; Cussell D; Keen M; Sengupta U
    Clin Exp Immunol; 1983 Jun; 52(3):528-36. PubMed ID: 6191891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
    Mathew JM; Muthukkaruppan V
    Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the major antigenic determinants of the characteristic phenolic glycolipid from Mycobacterium leprae.
    Brett SJ; Payne SN; Draper P; Gigg R
    Clin Exp Immunol; 1984 Apr; 56(1):89-96. PubMed ID: 6201310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae.
    Kolk AH; Ho ML; Klatser PR; Eggelte TA; Kuijper S; de Jonge S; van Leeuwen J
    Clin Exp Immunol; 1984 Dec; 58(3):511-21. PubMed ID: 6439449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of antibodies in dried blood from earlobes of leprosy patients by enzyme-linked immunosorbent assay--a preliminary report.
    Wu QX; Ye GY; Zhou LL; Shu HW; Liu Q; Li XY; Ma ZX; Li ZW
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):565-70. PubMed ID: 3910746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serology of leprosy. II. Demonstration of specific antibodies to mycobacterium leprae by counter current electrophoresis.
    Jagannath C; Sengupta DN
    Lepr India; 1981 Oct; 53(4):513-7. PubMed ID: 7038297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to understanding the transmission of Mycobacterium leprae using molecular and immunological methods: results from the MILEP2 study.
    Smith WC; Smith CM; Cree IA; Jadhav RS; Macdonald M; Edward VK; Oskam L; van Beers S; Klatser P
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):269-77. PubMed ID: 15485283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.